Connor Clark & Lunn Investment Management Ltd. bought a new stake in Aehr Test Systems (NASDAQ:AEHR – Free Report) during the second quarter, HoldingsChannel.com reports. The fund bought 670,758 shares of the semiconductor company’s stock, valued at approximately $64,433,000.
Several other institutional investors have also recently bought and sold shares of AEHR. BlackRock Inc. acquired a new position in Aehr Test Systems during the 2nd quarter worth approximately $255,476,000. Wellington Management Group LLP grew its stake in shares of Aehr Test Systems by 129.9% during the 4th quarter. Wellington Management Group LLP now owns 830,664 shares of the semiconductor company’s stock worth $16,771,000 after acquiring an additional 469,400 shares in the last quarter. Invesco Ltd. raised its holdings in shares of Aehr Test Systems by 1,137.2% in the third quarter. Invesco Ltd. now owns 366,570 shares of the semiconductor company’s stock valued at $11,037,000 after purchasing an additional 336,940 shares during the last quarter. Next Century Growth Investors LLC raised its holdings in shares of Aehr Test Systems by 99.9% in the fourth quarter. Next Century Growth Investors LLC now owns 552,506 shares of the semiconductor company’s stock valued at $11,155,000 after purchasing an additional 276,160 shares during the last quarter. Finally, Halter Ferguson Financial Inc. raised its holdings in shares of Aehr Test Systems by 41.7% in the fourth quarter. Halter Ferguson Financial Inc. now owns 642,129 shares of the semiconductor company’s stock valued at $12,965,000 after purchasing an additional 189,117 shares during the last quarter. Institutional investors own 69.69% of the company’s stock.
Analyst Upgrades and Downgrades
AEHR has been the subject of several recent research reports. Weiss Ratings cut shares of Aehr Test Systems from a “sell (d)” rating to a “sell (e+)” rating in a report on Wednesday, July 29th. Jefferies Financial Group started coverage on shares of Aehr Test Systems in a research note on Thursday, August 13th. They issued a “buy” rating and a $175.00 price target on the stock. Lake Street Capital restated a “buy” rating and set a $110.00 price objective on shares of Aehr Test Systems in a research note on Wednesday, July 15th. Freedom Capital raised shares of Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 16th. Finally, Craig Hallum restated a “buy” rating and set a $125.00 price objective on shares of Aehr Test Systems in a research note on Wednesday, July 15th. Two research analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Buy” and an average target price of $136.67.
Aehr Test Systems Price Performance
AEHR opened at $101.73 on Monday. Aehr Test Systems has a 12-month low of $17.33 and a 12-month high of $147.40. The business has a 50 day moving average of $94.63 and a 200-day moving average of $74.93. The stock has a market cap of $3.32 billion, a price-to-earnings ratio of -423.86 and a beta of 3.10.
Insiders Place Their Bets
In related news, Director Rhea J. Posedel sold 5,973 shares of the stock in a transaction on Friday, August 14th. The stock was sold at an average price of $140.00, for a total value of $836,220.00. Following the sale, the director owned 381,989 shares in the company, valued at approximately $53,478,460. This represents a 1.54% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Alberto Salamone sold 9,672 shares of the firm’s stock in a transaction on Thursday, August 13th. The shares were sold at an average price of $127.72, for a total value of $1,235,307.84. Following the sale, the executive vice president directly owned 41,962 shares of the company’s stock, valued at $5,359,386.64. This represents a 18.73% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 109,475 shares of company stock worth $13,827,160 in the last quarter. Company insiders own 6.80% of the company’s stock.
Aehr Test Systems Profile
Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.
The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.
Further Reading
- Five stocks we like better than Aehr Test Systems
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding AEHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aehr Test Systems (NASDAQ:AEHR – Free Report).
Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.
